UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

The New England journal of medicine, 2018-05, Vol.378 (21), p.1976-1986

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas

Annals of oncology, 2020-05, Vol.31 (5), p.599-608

2020

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Annals of oncology, 2018-10, Vol.29 (10), p.2085-2091

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers

Annals of oncology, 2016-07, Vol.27 (7), p.1286-1291

2016

Link zum Volltext

Verfügbarkeit prüfen

Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells

Genes & development, 1999-06, Vol.13 (11), p.1398-1411

1999

Link zum Volltext

Verfügbarkeit prüfen

OA20.05 The International Association for the Study of Lung Cancer Grading System for Recurrence and Lung Cancer-Specific Survival

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S91-S92

2023

Link zum Volltext

Verfügbarkeit prüfen

1385P Genomics of early progression on selpercatinib in patients with RET fusion-positive lung cancers

Annals of oncology, 2023-10, Vol.34, p.S794-S795

2023

Link zum Volltext

Verfügbarkeit prüfen

OA06.01 Validation of the 8th Ed TNM: Invasive Size for Pathologic T Descriptor in Stage I-IIA Resected Nonmucinous Adenocarcinomas

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S855-S856

2021

Link zum Volltext

Verfügbarkeit prüfen

EP16.03-030 AKT Inhibition as a Therapeutic Strategy to Constrain Histological Transdifferentiation in EGFR-mutant Lung Adenocarcinoma

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S602

2022

Link zum Volltext

Verfügbarkeit prüfen

P38.04 3D Analysis of Spread Through Air Spaces in Squamous Cell Carcinoma and Carcinoid Tumor Using Whole Block Imaging by Micro CT

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S458-S459

2021

Link zum Volltext

Verfügbarkeit prüfen

ES12.05 Impact of STAS in Lung Cancer Staging

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S45-S45

2019

Link zum Volltext

Verfügbarkeit prüfen

Mucocutaneous bullous amyloidosis with an unusual mixed protein composition of amyloid deposits

British journal of dermatology (1951), 2006-04, Vol.154 (4), p.751-754

2006

Link zum Volltext

Verfügbarkeit prüfen

MA22.05 Impact of Tumor Spread Through Air Spaces (STAS) in Lung Neuroendocrine Tumors (NETs)

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S434-S435

2018

Link zum Volltext

Verfügbarkeit prüfen

MS10.04 Therapeutic Implications of Spread Through Air Spaces (STAS)

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S265-S266

2018

Link zum Volltext

Verfügbarkeit prüfen

MA09.06 The Newly Recognized Filigree Pattern of Micropapillary (MIP) Lung Adenocarcinoma (LADC) is as Clinically Important as the Classical Pattern

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S386-S387

2018

Link zum Volltext

Verfügbarkeit prüfen

1MO Multi-omic characterization of lung tumors identify AKT and EZH2 as potential therapeutic targets in adenocarcinoma-to-squamous transdifferentiation

Annals of oncology, 2021-10, Vol.32, p.S1345

2021

Link zum Volltext

Verfügbarkeit prüfen

1800O Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation

Annals of oncology, 2021-09, Vol.32, p.S1226-S1226

2021

Link zum Volltext

Verfügbarkeit prüfen

OA03.07 Three-Dimensional Immunofluorescence Analysis of Dynamic Vessel Co-Option of Spread Through Air Spaces (STAS) in Lung Cancer

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S327-S327

2018

Link zum Volltext

Verfügbarkeit prüfen

MA11.06 Multi-Omic Characterization of Lung Tumors Implicates AKT and MYC Signaling in Adenocarcinoma to Squamous Cell Transdifferentiation

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S919-S919

2021

Link zum Volltext

Verfügbarkeit prüfen

OA 18.06 Three-Dimensional Assessment of Spread Through Air Spaces in Lung Adenocarcinoma: Insights and Implications

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1797-S1797

2017

Link zum Volltext

Verfügbarkeit prüfen

P3.13-019 Preoperative Needle Biopsy Does Not Increase the Risk of Pleural Recurrence in ≤3cm Lung Adenocarcinoma

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2323-S2323

2017

Link zum Volltext

Verfügbarkeit prüfen

A07 The Genomic Landscape of SMARCA4 Alterations and Association with Patient Outcomes in Lung Cancer

Journal of thoracic oncology, 2020-02, Vol.15 (2), p.S14-S14

2020

Link zum Volltext

Verfügbarkeit prüfen

MA16.04 Clinical and Molecular Characteristics of EGFR Mutant Lung Cancers with Concurrent TP53 and RB1 Mutations

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S412-S412

2018

Link zum Volltext

Verfügbarkeit prüfen

P1.14-06 Tissue-Based Molecular and Histologic Landscape of Acquired Resistance to Osimertinib in Patients with EGFR-Mutant Lung Cancers

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S554-S554

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(113)
Berichte
(1)

Sprache

Englisch
(90)
Russisch
(26)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Humans
(34)
Life Sciences & Biomedicine
(34)
Male
(29)
Animals
(21)
Middle Aged
(17)
Female
(16)
Adult
(14)
Rats
(13)
Oncology
(12)
Aged
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Lung Neoplasms - Genetics
(10)
Seizures - Physiopathology
(10)
Mutation
(9)
Medicine, Research & Experimental
(8)
Research & Experimental Medicine
(8)
Tetanus Toxin
(8)
Adolescent
(7)
Disease-Free Survival
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers

Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells

OA20.05 The International Association for the Study of Lung Cancer Grading System for Recurrence and Lung Cancer-Specific Survival

1385P Genomics of early progression on selpercatinib in patients with RET fusion-positive lung cancers

OA06.01 Validation of the 8th Ed TNM: Invasive Size for Pathologic T Descriptor in Stage I-IIA Resected Nonmucinous Adenocarcinomas

EP16.03-030 AKT Inhibition as a Therapeutic Strategy to Constrain Histological Transdifferentiation in EGFR-mutant Lung Adenocarcinoma

P38.04 3D Analysis of Spread Through Air Spaces in Squamous Cell Carcinoma and Carcinoid Tumor Using Whole Block Imaging by Micro CT

ES12.05 Impact of STAS in Lung Cancer Staging

Mucocutaneous bullous amyloidosis with an unusual mixed protein composition of amyloid deposits

MA22.05 Impact of Tumor Spread Through Air Spaces (STAS) in Lung Neuroendocrine Tumors (NETs)

MS10.04 Therapeutic Implications of Spread Through Air Spaces (STAS)

MA09.06 The Newly Recognized Filigree Pattern of Micropapillary (MIP) Lung Adenocarcinoma (LADC) is as Clinically Important as the Classical Pattern

1MO Multi-omic characterization of lung tumors identify AKT and EZH2 as potential therapeutic targets in adenocarcinoma-to-squamous transdifferentiation

1800O Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation

OA03.07 Three-Dimensional Immunofluorescence Analysis of Dynamic Vessel Co-Option of Spread Through Air Spaces (STAS) in Lung Cancer

MA11.06 Multi-Omic Characterization of Lung Tumors Implicates AKT and MYC Signaling in Adenocarcinoma to Squamous Cell Transdifferentiation

OA 18.06 Three-Dimensional Assessment of Spread Through Air Spaces in Lung Adenocarcinoma: Insights and Implications

P3.13-019 Preoperative Needle Biopsy Does Not Increase the Risk of Pleural Recurrence in ≤3cm Lung Adenocarcinoma

A07 The Genomic Landscape of SMARCA4 Alterations and Association with Patient Outcomes in Lung Cancer

MA16.04 Clinical and Molecular Characteristics of EGFR Mutant Lung Cancers with Concurrent TP53 and RB1 Mutations

P1.14-06 Tissue-Based Molecular and Histologic Landscape of Acquired Resistance to Osimertinib in Patients with EGFR-Mutant Lung Cancers

Suchergebnisse filtern